A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. - Ferrini PR; Grossi A; Vannucchi AM; Barosi G; Guarnone R; Piva N; Musto P; Balleari E (British journal of haematology, 1998)